Classical Hodgkin lymphoma pediatric · 5 regimens
Cost vs Efficacy
| Regimen | Biomarker | Cost/cycle ↓ | Cycle | PFS ↕ | OS ↕ | Est. cycles | Course cost ↕ | Evidence |
|---|---|---|---|---|---|---|---|---|
ABVE-PC N/A - secondary systemic drug Partial | — | R 5 210 | 21d | — | — | — | — | — |
ABVE Variant #01 | — | R 2 639 | 28d | — | — | — | — | — |
OPPA Variant #01 Partial | — | R 1 451 | 28d | — | — | — | — | — |
VAMP (Methotrexate) Variant #01 | — | R 1 107 | 28d | — | — | — | — | — |
MOPP Variant #01 Partial | — | R 426 | 28d | — | — | — | — | — |
5 of 5 regimens shown